Elektrofi has a total of 40 patents globally, out of which 5 have been granted. Of these 40 patents, more than 70% patents are active. The United States of America is where Elektrofi has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Elektrofi.
Elektrofi was founded in 2016. By improving the patient experience, Elektrofi, a preclinical stage company, aims to redefine the norm for drug delivery.
Do read about some of the most popular patents of Elektrofi which have been covered by us in this article and also you can find Elektrofi patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Elektrofi patent portfolio.
How many patents does Elektrofi have?
Elektrofi has a total of 40 patents globally. These patents belong to 10 unique patent families. Out of 40 patents, 28 patents are active.
How Many Patents did Elektrofi File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Elektrofi Applications Filed | Elektrofi Patents Granted |
| 2023 | 3 | 3 |
| 2022 | 3 | 1 |
| 2021 | 12 | 1 |
| 2020 | 8 | – |
| 2019 | 2 | – |
| 2018 | 4 | – |
| 2017 | 6 | – |
| 2016 | 2 | – |
How many Elektrofi patents are Alive/Dead?
Worldwide Patents
How Many Patents did Elektrofi File in Different Countries?
Countries in which Elektrofi Filed Patents
| Country | Patent |
| United States Of America | 12 |
| Australia | 7 |
| Europe | 5 |
| China | 4 |
| Japan | 2 |
Where are Research Centers of Elektrofi Patents Located?
The research center of all the Elektrofi patents is the United States of America.
10 Best Elektrofi Patents
WO2018098376A1 is the most popular patent in the Elektrofi portfolio. It has received 18 citations so far from companies like Heilongjiang Xinhecheng Biotechnology, Zhang Jing , Iltrafe.
Below is the list of 10 most cited patents of Elektrofi:
| Publication Number | Citation Count |
| WO2018098376A1 | 18 |
| WO2019023392A1 | 16 |
| WO2020160323A2 | 11 |
| WO2019226969A1 | 9 |
| US20210220289A1 | 6 |
| CN110087763A | 5 |
| WO2021168271A1 | 5 |
| US11077059B2 | 4 |
| US20210322317A1 | 4 |
| WO2021212019A1 | 4 |
What Percentage of Elektrofi US Patent Applications Were Granted?
Elektrofi (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 66.67%.
Below are the key stats of Elektrofi patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Elektrofi?
| Law Firm | Total Applications | Success Rate |
| Hamilton Brook Smith & Reynolds P C | 7 | 100.0% |
| Clark & Elbing Llp | 1 | 0% |
| Jason Norris | 1 | 0.0% |
List of Elektrofi patents
| Elektrofi Patents | Title |
| US11717488B2 | Particle Formation And Morphology |
| US11654112B2 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| US11459376B2 | Compositions And Methods For The Delivery Of Therapeutic Biologics For Treatment Of Disease |
| US11077059B2 | Electrospraying Formation Of Particles Including Agents |
| US20230338299A1 | Particle Formation And Morphology |
| US20230181473A1 | Methods Of Forming Particles By Continuous Droplet Formation And Dehydration |
| US20230094393A1 | Peptide Particles And Methods Of Formation |
| US20230065628A1 | Droplet Formation And Particle Morphology |
| US20220389084A1 | Compositions And Methods For The Delivery Of Therapeutic Biologics For Treatment Of Disease |
| US20210322317A1 | Formation Of Particles Including Agents |
| US20210220289A1 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| EP4135667A1 | Methods Of Forming Particles By Continuous Droplet Formation And Dehydration |
| EP4027978A1 | Compositions And Methods For The Delivery Of Therapeutic Biologics For Treatment Of Disease |
| EP3917500A2 | Particle Formation And Morphology |
| EP3658612A4 | Formation Of Particles Including Agents |
| EP3544724A4 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| CN115484934A | Method Of Forming Particles By Continuous Droplet Formation And Dehydration |
| CN114514035A | Compositions And Methods For Delivery Of Therapeutic Biologics For Treatment Of Disease |
| CN113365609A | Particle Formation And Morphology |
| CN110087763A | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| WO2022256840A3 | Methods For Screening Particle Formulations Comprising Proteins |
| JP7341061B2 | Particles Containing Therapeutic Or Diagnostic Agents And Their Suspensions And Methods Of Use |
| JP2023109799A | Particles Containing Therapeutic Or Diagnostic Agents And Their Suspensions And Methods Of Use |
| AU2023204413A1 | Formation Of Particles Including Agents |
| AU2022271378A1 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| AU2021257476A1 | Methods Of Forming Particles By Continuous Droplet Formation And Dehydration |
| AU2020344675A1 | Compositions And Methods For The Delivery Of Therapeutic Biologics For Treatment Of Disease |
| AU2020214626A1 | Particle Formation And Morphology |
| US20170137971A1 | Electrospinning |
| WO2021212019A1 | Methods Of Forming Particles By Continuous Droplet Formation And Dehydration |
| WO2021158959A3 | Peptide Comprising Particles And Methods Of Manufacturing |
| WO2021168271A1 | Droplet Formation And Particle Morphology |
| WO2021050953A8 | Compositions And Methods For The Delivery Of Therapeutic Biologics For Treatment Of Disease |
| WO2020160323A2 | Particle Formation And Morphology |
| WO2019226969A1 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| WO2019023392A1 | Formation Of Particles Including Agents |
| WO2018098376A1 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
| WO2017083187A1 | Electrospinning |
| AU2018306303A1 | Formation Of Particles Including Agents |
| AU2017364077A1 | Particles Comprising A Therapeutic Or Diagnostic Agent And Suspensions And Methods Of Use Thereof |
What are Elektrofi key innovation segments?
What Technologies are Covered by Elektrofi?
The chart below distributes patents filed by Elektrofi